Zydus Lifesciences Q1 FY27: PAT down 36% to Rs 940 cr as revenue rose 22% to Rs 8,017 cr; margins fell; US biosimilar launch and Assertio buy.
The Silicon Valley giant – worth a whopping $965 billion – is targeting a stock market debut this fall that could surpass Elon Musk’s mammoth SpaceX IPO, though the AI industry is facing several hurdles that have left investors wary.
Rackspace Technology (NASDAQ:RXT) reported second-quarter revenue of $670 million, up 1% from a year earlier, as the company outlined an expanded enterprise...
Chicago Atlantic Real Estate Finance (NASDAQ:REFI) reported second-quarter distributable earnings of $0.44 per basic weighted average common share, below its...
Middleby (NASDAQ:MIDD) said its transformation into a focused commercial foodservice equipment company is complete after the company sold a controlling stake...
